Release Date: 13/01/20 10:07 Summary: Director Appointment/Resignation Price Sensitive: No Download Document 235.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%